ADAMTS4 and triple-A syndrome: The administration of the ADAMTS4-specific probe in the first week resulted in a significant increase of 88% in MR signal in animals, suffering from an extensive AAA progression as visible in MRI after 4 weeks (n = 6; P < 0.01).